Sigyn Therapeutics SIGY
OTC SIGY
$0.04 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sigyn Therapeutics, Inc. (SIGY) Convertible Debt (2016 - 2020)

Updated

Sigyn Therapeutics (SIGY) posted Convertible Debt of $1.8 million for Q3 2020, up 1.4% from $1.77 million a year earlier and unchanged from the prior quarter.

Analysis

Sigyn Therapeutics, Inc. (SIGY) Convertible Debt (2016 - 2020) Analysis & Trends

Since Q4 2016, Sigyn Therapeutics has reported Convertible Debt for 12 quarters.

  • In prior years, Sigyn Therapeutics' Convertible Debt was $1.73 million in FY2018 (+20.5%) and $1.44 million in FY2017.
  • Quarterly Convertible Debt has run from a low of $17,505 in Q2 2017 to a high of $1.8 million in Q4 2019 over five years.
  • On a year-over-year basis, Convertible Debt has increased in each of the last four quarters, with growth averaging 89.3% over the last six quarters.
  • According to Business Quant data, Convertible Debt for the three prior quarters was $1.8 million (Q2 2020), $1.8 million (Q1 2020) and $1.8 million (Q4 2019).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 1.80 Mn
Jun 30, 2020 1.80 Mn
Mar 31, 2020 1.80 Mn
Dec 31, 2019 1.80 Mn
Sep 30, 2019 1.77 Mn
Jun 30, 2019 1.73 Mn
Mar 31, 2019 1.73 Mn
Dec 31, 2018 1.73 Mn
Mar 31, 2018 287,502.00
Dec 31, 2017 1.44 Mn
Jun 30, 2017 17,505.00
Dec 31, 2016 30,780.00
API Access

Sigyn Therapeutics, Inc. Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=SIGY&period=max&api_key=YOUR_API_KEY